Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationJoanna M. Wardlaw, Martin Dichgans, Carol Brayne et al.|The Lancet Neurology|2013Cited by 5.4k
Imaging markers for Alzheimer diseaseGiovanni B. Frisoni, Martina Bocchetta, Gaël Chételat et al.|Neurology|2013Cited by 223
Polygenic risk of Alzheimer disease is associated with early- and late-life processesElizabeth C. Mormino, Robert A. Koeppe, Reisa A. Sperling et al.|Neurology|2016Cited by 196
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s PathophysiologyXinpeng Shen, Matthew L. Senjem, Sisi Ma et al.|Scientific Reports|2020Cited by 135
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s diseaseAlexa Pichet Binette, Virginia Lee, Nicolai Franzmeier et al.|Nature Communications|2022Cited by 129